ProVise Management Group LLC decreased its holdings in shares of iShares Biotechnology ETF ( NASDAQ:IBB – Free Report ) by 4.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,578 shares of the financial services provider's stock after selling 541 shares during the quarter. ProVise Management Group LLC's holdings in iShares Biotechnology ETF were worth $1,495,000 as of its most recent filing with the Securities and Exchange Commission.

https://www.dailypolitical.com/2023/08/06/ishares-biotechnology-etf-nasdaqibb-shares-sold-by-provise-management-group-llc.html

#dailypolitical